289 related articles for article (PubMed ID: 32849303)
1. Thyroid Hormone Supplementation Therapy for Differentiated Thyroid Cancer After Lobectomy: 5 Years of Follow-Up.
Kim SY; Kim HJ; Kim SM; Chang H; Lee YS; Chang HS; Park CS
Front Endocrinol (Lausanne); 2020; 11():520. PubMed ID: 32849303
[No Abstract] [Full Text] [Related]
2. Clinical Features of Early and Late Postoperative Hypothyroidism After Lobectomy.
Park S; Jeon MJ; Song E; Oh HS; Kim M; Kwon H; Kim TY; Hong SJ; Shong YK; Kim WB; Sung TY; Kim WG
J Clin Endocrinol Metab; 2017 Apr; 102(4):1317-1324. PubMed ID: 28324106
[TBL] [Abstract][Full Text] [Related]
3. Prediction of thyroid hormone supplementation after thyroid lobectomy.
Lee DY; Seok J; Jeong WJ; Ahn SH
J Surg Res; 2015 Jan; 193(1):273-8. PubMed ID: 25088372
[TBL] [Abstract][Full Text] [Related]
4. The Recovery of Thyroid Function in Low-Risk Papillary Thyroid Cancer After Lobectomy: A 3-Year Follow-Up Study.
Dou Y; Chen Y; Hu D; Su X
Front Endocrinol (Lausanne); 2020; 11():619841. PubMed ID: 33633689
[TBL] [Abstract][Full Text] [Related]
5. Levothyroxine Cessation After Thyroid Lobectomy for Papillary Thyroid Cancer Can Be Achieved at the Same Rate as that for Benign Tumors Regardless of the Duration of Thyroid-stimulating Hormone Suppression.
Na YM; Cho JS; Park MH
Anticancer Res; 2021 Nov; 41(11):5713-5721. PubMed ID: 34732444
[TBL] [Abstract][Full Text] [Related]
6. Oncological impact of hypothyroidism and levothyroxine supplementation following hemithyroidectomy in patients with papillary thyroid carcinoma.
Ahn D; Lee GJ; Sohn JH; Jeon JH
Head Neck; 2020 May; 42(5):1004-1013. PubMed ID: 31930773
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for hypothyroidism and thyroid hormone replacement after hemithyroidectomy in papillary thyroid carcinoma.
Lee SJ; Song CM; Ji YB; Choi YY; Sohn YS; Park JH; Kim DS; Tae K
Langenbecks Arch Surg; 2021 Jun; 406(4):1223-1231. PubMed ID: 33970335
[TBL] [Abstract][Full Text] [Related]
8. Is thyroid hormone supplementation avoidable for patients with low-risk papillary thyroid cancer after thyroid lobectomy? A two-center observational study.
Xiao L; Wu J; Jiang L; Xu Y; Liu B
Clin Endocrinol (Oxf); 2022 Mar; 96(3):413-418. PubMed ID: 34398464
[TBL] [Abstract][Full Text] [Related]
9. Postoperative thyroid hormone supplementation rates following thyroid lobectomy.
Wilson M; Patel A; Goldner W; Baker J; Sayed Z; Fingeret AL
Am J Surg; 2020 Nov; 220(5):1169-1173. PubMed ID: 32684294
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with postoperative hypothyroidism after lobectomy in papillary thyroid microcarcinoma patients.
Park HK; Kim DW; Ha TK; Choo HJ; Park YM; Jung SJ; Kim DH; Bae SK
Endocr Res; 2015; 40(1):49-53. PubMed ID: 25111668
[TBL] [Abstract][Full Text] [Related]
11. Effects of endocrine therapy on the prognosis of elderly patients after surgery for papillary thyroid carcinoma.
Xia Q; Dong S; Bian PD; Wang J; Li CJ
Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):1037-43. PubMed ID: 25744048
[TBL] [Abstract][Full Text] [Related]
12. Biochemical Markers Reflecting Thyroid Function in Athyreotic Patients on Levothyroxine Monotherapy.
Ito M; Miyauchi A; Hisakado M; Yoshioka W; Ide A; Kudo T; Nishihara E; Kihara M; Ito Y; Kobayashi K; Miya A; Fukata S; Nishikawa M; Nakamura H; Amino N
Thyroid; 2017 Apr; 27(4):484-490. PubMed ID: 28056660
[TBL] [Abstract][Full Text] [Related]
13. Predictors of thyroxine replacement following hemithyroidectomy in a south east Asian cohort.
Ng P; Ho C; Tan WB; Ngiam KY; Lim CM; Thomas Loh KS; Nga ME; Parameswaran R
Head Neck; 2019 May; 41(5):1463-1467. PubMed ID: 30597664
[TBL] [Abstract][Full Text] [Related]
14. Postoperative thyroid hormone supplementation rates following thyroid lobectomy.
Wilson M; Patel A; Goldner W; Baker J; Sayed Z; Fingeret AL
Am J Surg; 2021 Apr; 221(4):804-808. PubMed ID: 32682499
[TBL] [Abstract][Full Text] [Related]
15. Thyroid stimulating hormone suppression and recurrence after thyroid lobectomy for papillary thyroid carcinoma.
Bae MR; Nam SH; Roh JL; Choi SH; Nam SY; Kim SY
Endocrine; 2022 Feb; 75(2):487-494. PubMed ID: 34689317
[TBL] [Abstract][Full Text] [Related]
16. Detection and management of hypothyroidism following thyroid lobectomy: evaluation of a clinical algorithm.
Johner A; Griffith OL; Walker B; Wood L; Piper H; Wilkins G; Baliski C; Jones SJ; Wiseman SM
Ann Surg Oncol; 2011 Sep; 18(9):2548-54. PubMed ID: 21547704
[TBL] [Abstract][Full Text] [Related]
17. Thyroid hormone replacement after thyroid lobectomy.
Stoll SJ; Pitt SC; Liu J; Schaefer S; Sippel RS; Chen H
Surgery; 2009 Oct; 146(4):554-8; discussion 558-60. PubMed ID: 19789012
[TBL] [Abstract][Full Text] [Related]
18. The magnitude of increased Levothyroxine dose during pregnancy in patients on thyroid-stimulating hormone (TSH) suppression treatment after total thyroidectomy for papillary carcinoma.
Minakata M; Ito M; Kishi T; Hada M; Masaki Y; Nakamura T; Kousaka K; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Akamizu T; Miyauchi A
Endocr J; 2022 Feb; 69(2):165-172. PubMed ID: 34526424
[TBL] [Abstract][Full Text] [Related]
19. Thyroid lobectomy for indeterminate FNA: not without consequences.
Balentine CJ; Domingo RP; Patel R; Laucirica R; Suliburk JW
J Surg Res; 2013 Sep; 184(1):189-92. PubMed ID: 23777982
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for thyroid hormone replacement therapy after hemithyroidectomy and development of a predictive nomogram.
Cao Z; Liu R; Wu M; Xu X; Liu Z
Endocrine; 2022 Apr; 76(1):85-94. PubMed ID: 35067900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
